1型糖尿病患者医疗器械相关皮炎患病率系统综述与问卷研究
研究发现皮肤反应很少被明确描述,不同中心诊断流程和转诊途径存在差异,且医疗器械成分未声明、检测材料未更新导致正确诊断延迟或受阻。
要点
- 1型糖尿病患者使用医疗器械相关皮炎患病率数据不足,且皮肤反应类型常未明确。
- 不同欧洲中心对疑似医疗器械变应性接触性皮炎的转诊和诊断流程不统一。
- 器械成分未声明及检测材料滞后是正确诊断延迟或受阻的主要原因。
核心结论
- 需要更多关于1型糖尿病患者医疗器械相关皮肤反应患病率的数据,尤其是皮肤反应被正确诊断的研究。
- 欧洲范围内应标准化转诊流程以改进疑似医疗器械变应性接触性皮炎的诊断程序。
研究设计与样本
- 采用Newcastle-Ottawa量表评估研究质量。
- 在EECDRG诊所进行问卷调查,聚焦转诊途径、患者数量和诊断流程。
主要发现
- 共筛选3145篇摘要,39项研究符合纳入标准。
- 参与者暴露于多种医疗器械,但皮肤反应很少被明确描述。
- 不同中心的诊断流程和转诊途径存在差异。
临床怎么用
- 临床接诊1型糖尿病患者时需关注医疗器械相关皮肤反应,但当前诊断流程不统一,应推动标准化转诊。
- 怀疑变应性接触性皮炎时,因器械成分未声明且检测材料未更新,正确诊断可能延迟或受阻。
局限性
- 皮肤反应很少被明确描述,影响患病率数据的准确性。
- 医疗器械实际成分未声明、可能无通知变更,且市售检测材料未充分更新,妨碍正确诊断。
- 各中心诊断流程和转诊途径不同,可能导致结果异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Use of medical devices (MDs), that is, glucose sensors and insulin pumps, in patients with Type 1 diabetes mellitus (T1D) has proven an enormous advantage for disease control. Adverse skin reactions from these MDs may however hamper compliance. The objective of this study was to systematically review and analyse studies assessing the prevalence and incidence of dermatitis, including allergic contact dermatitis (ACD) related to MDs used in patients with T1D and to compare referral routes and the clinical investigation routines between clinics being part of the European Environmental and Contact Dermatitis Research Group (EECDRG). A systematic search of PubMed, EMBASE, CINAHL and Cochrane databases of full-text studies reporting incidence and prevalence of dermatitis in persons with T1D using MDs was conducted until December 2021. The Newcastle-Ottawa Scale was used to assess study quality. The inventory performed at EECRDG clinics focused on referral routes, patient numbers and the diagnostic process. Among the 3145 screened abstracts, 39 studies fulfilled the inclusion criteria. Sixteen studies included data on children only, 14 studies were on adults and nine studies reported data on both children and adults. Participants were exposed to a broad range of devices. Skin reactions were rarely specified. It was found that both the diagnostic process and referral routes differ in different centres. Further data on the prevalence of skin reactions related to MDs in individuals with T1D is needed and particularly studies where the skin reactions are correctly diagnosed. A correct diagnosis is delayed or hampered by the fact that, at present, the actual substances within the MDs are not declared, are changed without notice and the commercially available test materials are not adequately updated. Within Europe, routines for referral should be made more standardized to improve the diagnostic procedure when investigating patients with possible ACD from MDs.
引用
- von Kobyletzki LB, Ulriksdotter J, Sukakul T, et al. Prevalence of dermatitis including allergic contact dermatitis from medical devices used by children and adults with Type 1 diabetes mellitus: A systematic review and questionnaire study. J Eur Acad Dermatol Venereol. 2024. PMID: 38400603. doi:10.1111/jdv.19908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。